Paper · 7923116

The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia.

Canman CE and 4 others. Cancer Res, 1994. Cited by 217 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia. Papers, record 7923116. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7923116

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia.; PubMed
Journal: Cancer Res; PubMed
Year: 1994; PubMed
Publication types: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/7923116/; PubMed
The journal: https://conductscience.org/library/journal-index/2984705R; PubMed
Citations, by iCite: 217; iCite
Relative citation ratio, by iCite: 3.93; iCite
Revised in PubMed: 2021-10-22; PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Canman CE	C E
2	Wolff AC	A C
3	Chen CY	C Y
4	Fornace AJ Jr	A J
5	Kastan MB	M B

Source PubMed

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Ataxia Telangiectasia	Major topic
G1 Phase	Major topic
Tumor Suppressor Protein p53	Major topic
DNA Damage
Humans
Methyl Methanesulfonate

Source PubMed

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes it	Agency	Country	NIH project	Stated by	Source
ES05777	NIEHS NIH HHS	United States	R01ES005777	PubMed and NIH	NIH RePORTER
T32CA60441	NCI NIH HHS	United States	T32CA060441	PubMed and NIH	NIH RePORTER
			R37ES005777	NIH	NIH RePORTER

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by73

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 217 citations.

PMID	Title	Journal	Year	In Papers	Source
40,341,728	RNA demethylase ALKBH5 regulates cell cycle progression in DNA damage response.	Sci Rep	2025	https://conductscience.org/library/papers/40341728	PubMed
33,816,280	Progressive Study on the Non-thermal Effects of Magnetic Field Therapy in Oncology.	Front Oncol	2021	https://conductscience.org/library/papers/33816280	PubMed
33,411,764	Novel modulators of p53-signaling encoded by unknown genes of emerging viruses.	PLoS Pathog	2021	https://conductscience.org/library/papers/33411764	PubMed
32,069,815	Extracellular Matrix Features Discriminate Aggressive HER2-Positive Breast Cancer Patients Who Benefit from Trastuzumab Treatment.	Cells	2020	https://conductscience.org/library/papers/32069815	PubMed
28,374,143	DNA damage response and hematological malignancy.	Int J Hematol	2017	https://conductscience.org/library/papers/28374143	PubMed
28,271,657	DNA damage response is hijacked by human papillomaviruses to complete their life cycle.	J Zhejiang Univ Sci B	2017	https://conductscience.org/library/papers/28271657	PubMed
28,256,581	Transcriptional and post-transcriptional regulation of the ionizing radiation response by ATM and p53.	Sci Rep	2017	https://conductscience.org/library/papers/28256581	PubMed
25,327,558	A phase I trial of the HIV protease inhibitor nelfinavir in adults with solid tumors.	Oncotarget	2014	https://conductscience.org/library/papers/25327558	PubMed
24,746,758	SOX2 expression is an early event in a murine model of EGFR mutant lung cancer and promotes proliferation of a subset of EGFR mutant lung adenocarcinoma cell lines.	Lung Cancer	2014	https://conductscience.org/library/papers/24746758	PubMed
24,266,355	Regulation of the life cycle of HPVs by differentiation and the DNA damage response.	Future Microbiol	2013	https://conductscience.org/library/papers/24266355	PubMed

1 to 10 of 73

See all 73 cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Gene	NCBI Gene ID	Linked by	In Genes	Source
CDKN1A	1,026	PubTator's text mining	https://conductscience.org/library/genes/1026	NCBI Gene
GADD45A	1,647	PubTator's text mining	https://conductscience.org/library/genes/1647	NCBI Gene
MDM2	4,193	PubTator's text mining	https://conductscience.org/library/genes/4193	NCBI Gene
TP53	7,157	PubTator's text mining	https://conductscience.org/library/genes/7157	NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7923116

GET https://conductscience.org/api/papers/v1/7923116/cited_by?page=2

API reference For AI assistants